LEADER 00871nam0-22002891i-450-
001 990001122200403321
005 20091105163120.0
010   $a90-277-2438-5
035   $a000112220
035   $aFED01000112220
035   $a(Aleph)000112220FED01
035   $a000112220
100   $a20001205d1987----km-y0itay50------ba
101 0 $aeng
200 1 $aSymplectic Geometry and Analytical Mechanics$fPaulette Libermann and Charles- Michel Marle
210   $aDordrecht (NL)$cReidel$d1987
610 0 $aGeometria descrittiva, analitica, differenziale
676   $a514
700  1$aLibermann,$bPaulette$027867
702  1$aMarle,$bCharles-Michel
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990001122200403321
952   $a12-144F$b20149$fFI1
959   $aFI1
996   $aSymplectic Geometry and Analytical Mechanics$9337010
997   $aUNINA

LEADER 01631oam  2200517zu 450 
001 9910830297303321
005 20210907021921.0
010   $a3-527-62707-3
035   $a(CKB)2500000000001720
035   $a(SSID)ssj0000507330
035   $a(PQKBManifestationID)11358811
035   $a(PQKBTitleCode)TC0000507330
035   $a(PQKBWorkID)10546078
035   $a(PQKB)10971425
035   $a(PPN)243320183
035   $a(EXLCZ)992500000000001720
100   $a20160829d2009      uy              
101 0 $aeng
181   $ctxt
182   $cc
183   $acr
200 00$aEpigenetic targets in drug discovery
210 31$a[Place of publication not identified]$cWiley VCH$d2009
225 0 $aMethods and principles in medicinal chemistry  Epigenetic targets in drug discovery
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a3-527-32355-4 
606   $aPharmacogenomics
606   $aEpigenesis, Genetic
606   $aDrug Discovery$xmethods
606   $aPharmacogenetics$xmethods
606   $aHealth & Biological Sciences$2HILCC
606   $aPharmacy, Therapeutics, & Pharmacology$2HILCC
615  0$aPharmacogenomics
615 12$aEpigenesis, Genetic.
615 22$aDrug Discovery$xmethods.
615 22$aPharmacogenetics$xmethods.
615  7$aHealth & Biological Sciences
615  7$aPharmacy, Therapeutics, & Pharmacology
676   $a615.7
702   $aSippl$b Wolfgang
702   $aJung$b Manfred
801  0$bPQKB
906   $aBOOK
912   $a9910830297303321
996   $aEpigenetic targets in drug discovery$93943486
997   $aUNINA